4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-058763
EVP, R&D & Chief Scientific Of sold 775 shares at $33.81 ($26,203)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2018-11-15 | Sale | −775 | $33.81 | $26,203 | 285,580 | D |
| Open-market sales · 775 sh · avg $33.81 · $26,203 | |||||||
Loading xslF345X03/doc4.xml…